Report post

Why is the Abbott stock price falling?

The stock price of Abbott (NYSE: ABT) has seen a fall of 7% in a month, while it declined 4% in a week. This can largely be attributed to its recent voluntary recall of three types of baby formula - Similac, Alimentum, and EleCare - all manufactured in its Sturgis plant and with an expiration of April 1 or later.

Is Abbott Laboratories stock a buy?

Abbott Laboratories stock has received a consensus rating of buy. The average rating score is Aa3 and is based on 49 buy ratings, 6 hold ratings, and 0 sell ratings. What was the 52-week low for Abbott Laboratories stock? The low in the last 52 weeks of Abbott Laboratories stock was 89.68.

Will Abbott (Abt) stock rise in the near-term?

We expect Abbott to report revenues and earnings above the consensus estimates, driven by continued growth in diagnostics business, along with a rebound in demand for medical devices. We expect the company to navigate well based on these trends over the latest quarter, and ABT stock to rise in the near term.

The World's Leading Crypto Trading Platform

Get my welcome gifts